Folic Acid with DHA/EPA
Natural health product licensed in Canada
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine B12 Source : Méthylcobalamine | 500 mcg | Not calculated |
Non-medicinal ingredients
Huile de fève de soja, Microcrystalline cellulose, Eau purifiée, Lécithine, Gélatine, Cire d'abeille, Poudre de caroube, Tocophérol, Glycérine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
A factor in maintenance of good health. Helps to reduce the risk of neural tube defects when taken daily prior to becoming pregnant and during early pregnancy. Helps the body to metabolize carbohydrates, fats and proteins. Helps to form red blood cells. Source of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) for the maintenance of good health. Source of omega-3 fatty acids for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Product record
- Other names
- Folic Acid, Folic Acid DHA/EPA Formula, Folic Acid EPA/DHA Formula, Folic Acid/DHA Formula
- Licence holder
- WN Pharmaceuticals Ltd
- NPN or DIN-HM
- 80038948
- Status
- Active licence
- Licence date
- 22 January 2013
- Revision date
- Not provided
- Form
- Capsule, enrobage gélatine
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80038948
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.